Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

George Freeman

Pharma reaction to the Government’s AAR review

October 27, 2015 Manufacturing and Production, Research and Development Accelerated Access Review

The long-awaited interim report on the Government’s Accelerated Access Review has been published.The Government department overseeing the report, the Office …
News
Shire image

New Phase III data puts Shire’s lifitegrast back on track for 2016 launch

October 27, 2015 Research and Development Shire, dry eye disease, lifitegrast

Shire shares rose 6% today as the company reported new positive Phase III trial data for lifitegrast in the treatment …
News
nhsa

North of England secures new ‘centres of excellence’ in ‘precision medicine’

October 27, 2015 Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK

The umbrella group formed by the leading northern universities, teaching hospitals and Academic Health Science Networks – the Northern Health …
News

Revealed: recommendations from the Accelerated Access Review

October 27, 2015 Manufacturing and Production, Research and Development Accelarated Access Review, NHS

Ministers have been urged to introduce conditional approvals for innovative new drugs, and ‘radically new’ central agreements on drug pricing, …
News
gsk_hq

GSK’s Volibris gets pulmonary arterial hypertension approval in Europe

October 26, 2015 Research and Development, Sales and Marketing EMA, GSK

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …
News
robert_langer

Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize

October 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize

Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.The award is in recognition …
Appointment
amgen_hq

Amgen skin cancer drug gets European approval

October 23, 2015 Research and Development Amgen, Imlygic, melanoma, skin cancer

Amgen’s Imlygic (talimogene laherparepvec) has been approved by the scientific committee of the European Medicines Agency (EMA) for the treatment of adults …
News
gilead-sciences

Gilead presents Phase III results for Genvoya in HIV

October 22, 2015 Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV

Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …
News
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015 Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
News
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015 Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
News
uk_china_flags_half_and_half

UK and China sign £2 billion in healthcare trade and investment deals

October 22, 2015 Research and Development

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …
News
Aspirin

World’s largest clinical trial of aspirin in cancer launches in UK

October 22, 2015 Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015 Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
News
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015 Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …
Feature

Global warning for governments to step up R&D spending

October 21, 2015 Research and Development

Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026